ICSI made safe, using recombinant human albumin.
Description Viscous sperm handling solution containing recombinant human albumin and PVP.
Purpose For the immobilisation and isolation of sperm prior to intracytoplasmic sperm injection, ICSI.
Application For use after pre-equilibration at +20 ± 5ºC and ambient atmosphere.
Storage Store dark at +2 to +8°C
ICSI is a viscous sperm handling solution designed to facilitate sperm immobilization and injection into the oocyte. It contains recombinant human albumin for safety and the most widely used molecule used for this purpose, polyvinylpyrrolidone or PVP. PVP is an inert molecule that does not take part in any metabolic pathway.
In 1992 science brought hope to thousands of childless couples when the first pregnancies generated by ICSI were reported. This meant that male infertility factor was less of an obstacle to starting a family.
At its introduction in the early 1990s, fertilisation rates after ICSI were around 30%1 . Thanks to further modifications of the procedure, fertilisation rates of over 80% are now possible and ICSI is now used as the method for fertilisation in around 65% of all treatment cycles globally
Short protocols G-Series ICSI
This short protocol describes how to perform ICSI using Vitrolife products.
Safety data sheets (SDS)
Safety data sheet for ICSI